TiFFANY TR

TR research associated with 'A multicenter Phase II basket-type clinical trial to evaluate efficacy and safety of TAS-120 in patients with advanced solid malignancies with FGFR alterations in circulating tumor DNA (TiFFANY study)'

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080224720

Enrollment

Registered

2019-06-10

Start date

2019-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid malignancies

Interventions

investigational material(s) Generic name etc : TAS-120 INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients enrolled in treatment group in 'A multicenter Phase II basket-type clinical trial to evaluate efficacy and safety of TAS-120 in patients with advanced solid malignancies with FGFR alterations in circulating tumor DNA(TiFFANY study)'

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
other Immunohistochemistry In situ hybridization Reverse Phase Protein Array Targeted sequencing RNA-seq Digital sequencing of ctDNA (Guardant360) Functional analysis (in vitro and in vivo)	—

Secondary

Measure	Time frame
other -	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026